DJIA 16,912.11 -70.48 -0.42%
NASDAQ 4,442.70 -2.21 -0.05%
S&P 500 1,969.95 -8.96 -0.45%
market minute promo

6.17 0.56 (9.98%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ARIA $6.17 9.98%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.66
Previous Close $5.61
Daily Range $5.60 - $6.28
52-Week Range $2.15 - $23.00
Market Cap $1.2B
P/E Ratio -4.01
Dividend (Yield) $0.00 (0.0%)
Volume 16,622,640
Average Daily Volume 8,548,730
Current FY EPS -$1.02

Sector

Healthcare

Industry

Drugs

Ariad Pharmaceuticals, Inc. (ARIA) Description

The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules. Website: http://www.ariad.com/

News & Commentary

ARIAD Pharmaceuticals, Inc. Battling Back

Since returning to market, ARIAD Pharmaceuticals has captured about half of the patients on Iclusig before it went off the market, but it'll have a hard time competing with Novartis' and Bristol-Myers Squibb's leukemia drugs.

Storm The Castle: ARIAD Pharmaceuticals (ARIA)

ARIAD Pharmaceuticals (ARIA) Showing Signs Of Perilous Reversal Today

3 Huge Stocks to Trade (or Not)

Ariad Pharmaceuticals (ARIA) Worth Watching: Stock Gains 15.3% - Tale of the Tape

Morning Market Movers

Benzinga's Top #PreMarket Gainers

'Fast Money' Recap: Facebook and Analysts' Expectations

Benzinga's M&A Chatter for Wednesday July 23, 2014

Thursday's ETF Movers: GDXJ, XBI

Yellen, Icahn Comments Put a Lid on Small-Cap Stocks, May Hurt Larger Market

See More ARIA News...

ARIA's Top Competitors

ARIA $6.17 (9.98%)
Current stock: ARIA
AMGN $123.31 (0.54%)
Current stock: AMGN
GILD $92.99 (1.67%)
Current stock: GILD
BIIB $341.73 (1.59%)
Current stock: BIIB